GSA Capital Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,247	Closed	-$469K	–	1235
2020 Q1	$469K	Buy	3,247 +1,897	+141%	+$274K	0.12%	199
2019 Q4	$276K	Buy	+1,350	New	+$276K	0.03%	1080
2018 Q1	–	Sell	-26,300	Closed	-$745K	–	1885
2017 Q4	$745K	Buy	+26,300	New	+$745K	0.05%	740